Clinical Trial Update: Axillary Reverse Mapping [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating axillary reverse mapping in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED